**Core Concept**
Tachyarrhythmias, such as supraventricular tachycardia (SVT), can present with severe hemodynamic instability, necessitating immediate intervention to restore a normal heart rhythm and improve cardiac output. In this scenario, the patient's refractoriness to vagal maneuvers and adenosine indicates a more complex arrhythmia that requires pharmacological or electrical cardioversion.

**Why the Correct Answer is Right**
The next step in managing this patient involves administering a medication that can effectively terminate the arrhythmia. **Amiodarone** is a Class III antiarrhythmic agent that can be used in this scenario. It works by blocking potassium channels, which helps to prolong the action potential duration and refractory period in the heart, thereby facilitating cardioversion. Amiodarone is particularly useful in patients who are refractory to adenosine and vagal maneuvers.

**Why Each Wrong Option is Incorrect**
**Option A:** **Phenylephrine** is a vasoconstrictor that can increase blood pressure but is not effective in terminating SVT. Its use in this scenario would not address the underlying arrhythmia.
**Option B:** **Atropine** is an anticholinergic agent that can increase heart rate and is not indicated in this scenario. Its use would further exacerbate the patient's hemodynamic instability.
**Option C:** **Metoprolol** is a beta-blocker that can slow heart rate but is not effective in terminating SVT. Its use in this scenario would not address the underlying arrhythmia.

**Clinical Pearl / High-Yield Fact**
In patients with SVT, the use of **adenosine** as a first-line treatment is recommended due to its high efficacy and rapid onset of action. However, in patients who are refractory to adenosine, amiodarone is a good second-line option.

**Correct Answer:** D. Amiodarone